Maravai LifeSciences Holdings, Inc. (MRVI) Financials

MRVI Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 713.2 million 344.1 million
Dec. 31, 2025 770.6 million 397.9 million
Sept. 30, 2025 849.2 million 417.3 million
June 30, 2025 897.0 million 429.0 million

MRVI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 4.2 million 6.7 million
Dec. 31, 2025 -24.9 million 3.9 million
Sept. 30, 2025 -18.1 million 9.1 million
June 30, 2025 -13.1 million 6.8 million

MRVI Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -3.7 million
Dec. 31, 2025 -40.1 million
Sept. 30, 2025 -25.6 million
June 30, 2025 -69.8 million

MRVI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 165.9 million 29.9 million -
Dec. 31, 2025 216.9 million 30.1 million 72.9 million
Sept. 30, 2025 243.6 million 30.4 million 75.1 million
June 30, 2025 269.9 million 288.4 million 69.7 million

MRVI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 146.4 million
Dec. 31, 2025 145.1 million
Sept. 30, 2025 144.7 million
June 30, 2025 144.2 million

MRVI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 4.4 million 3.9 million 27.3 million -
Dec. 31, 2025 2.1 million 3.8 million 15.2 million -
Sept. 30, 2025 2.9 million 9.8 million 78.1 million -
June 30, 2025 2.9 million 4.9 million 38.6 million -

MRVI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 65.8 million 32.1 million
Dec. 31, 2025 49.9 million 37.6 million
Sept. 30, 2025 41.6 million 36.0 million
June 30, 2025 47.4 million 39.6 million

MRVI Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MRVI

Price: $4.84

52 week price:
1.95
5.00

Earnings Per Share: -0.71 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.1 million

Market Capitalization: 1.7 billion

Links: